GILEAD SCIENCES, INC. 8-K

What Happened
Gilead Sciences, Inc. announced its financial results for the quarter ended March 31, 2026 in an 8-K filed May 7, 2026. The company filed a press release as Exhibit 99.1 reporting its quarterly performance and presented results on both a U.S. GAAP and a non‑GAAP basis. Management said it uses non‑GAAP measures for internal operating, budgeting and financial planning purposes and believes those measures are useful to investors when viewed alongside GAAP results.

Key Details

• Filing date: May 7, 2026; quarter covered: ended March 31, 2026.
• Press release attached as Exhibit 99.1 to the 8-K.
• Gilead provided both GAAP and non‑GAAP financial information; reconciliations are included in the press release on pages 10–12.
• Company noted that non‑GAAP measures are supplemental, not prepared under comprehensive accounting rules, and may differ from similarly named measures used by other companies.

Why It Matters
Earnings and quarterly financial results directly affect investor assessment of Gilead’s performance and outlook. The company’s use of non‑GAAP metrics—alongside reconciliations to GAAP—helps investors understand management’s view of underlying business trends but requires attention to the provided reconciliations to compare consistently with other firms and with GAAP results. The press release (Exhibit 99.1) is the primary source for the detailed figures and reconciliations.